Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.

Klompenhouwer AJ, Dwarkasing RS, Doukas M, Pellegrino S, Vilgrain V, Paradis V, Soubrane O, Beane JD, Geller DA, Nalesnik MA, Tripke V, Lang H, Schmelzle M, Pratschke J, Schöning W, Beal E, Sun S, Pawlik TM, de Man RA, Ijzermans JNM.

HPB (Oxford). 2019 Oct 13. pii: S1365-182X(19)30716-6. doi: 10.1016/j.hpb.2019.09.004. [Epub ahead of print]

PMID:
31619346
2.

Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Putra J, Ferrell LD, Gouw ASH, Paradis V, Rishi A, Sempoux C, Balabaud C, Thung SN, Bioulac-Sage P.

Mod Pathol. 2019 Sep 30. doi: 10.1038/s41379-019-0374-x. [Epub ahead of print]

PMID:
31570768
3.

Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.

Gigante E, Ronot M, Bertin C, Ciolina M, Bouattour M, Dondero F, Cauchy F, Soubrane O, Vilgrain V, Paradis V.

Liver Int. 2019 Sep 23. doi: 10.1111/liv.14261. [Epub ahead of print]

PMID:
31544304
4.

Comparison of pulsed and oscillating gradient diffusion-weighted MRI for characterizing hepatocellular nodules in liver cirrhosis: ex vivo study in a rat model.

Wagner M, Doblas S, Poté N, Lambert SA, Ronot M, Garteiser P, Paradis V, Vilgrain V, Van Beers BE.

J Magn Reson Imaging. 2019 Sep 11. doi: 10.1002/jmri.26919. [Epub ahead of print]

PMID:
31507025
5.

The 2019 WHO classification of tumours of the digestive system.

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington MK, Carneiro F, Cree IA.

Histopathology. 2019 Aug 21. doi: 10.1111/his.13975. [Epub ahead of print]

PMID:
31433515
6.

Adeno-associated virus in the liver: natural history and consequences in tumour development.

La Bella T, Imbeaud S, Peneau C, Mami I, Datta S, Bayard Q, Caruso S, Hirsch TZ, Calderaro J, Morcrette G, Guettier C, Paradis V, Amaddeo G, Laurent A, Possenti L, Chiche L, Bioulac-Sage P, Blanc JF, Letouze E, Nault JC, Zucman-Rossi J.

Gut. 2019 Aug 2. pii: gutjnl-2019-318281. doi: 10.1136/gutjnl-2019-318281. [Epub ahead of print]

PMID:
31375600
7.

Influence of pretreatment tumor growth rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization.

Purcell Y, Sartoris R, Paradis V, Vilgrain V, Ronot M.

J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14816. [Epub ahead of print]

PMID:
31369166
8.

ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.

Calderaro J, Meunier L, Nguyen CT, Boubaya M, Caruso S, Luciani A, Amaddeo G, Regnault H, Nault JC, Cohen J, Oberti F, Michalak S, Bouattour M, Vilgrain V, Pageaux GP, Ramos J, Barget N, Guiu B, Paradis V, Aubé C, Laurent A, Pawlotsky JM, Ganne-Carrié N, Zucman-Rossi J, Seror O, Ziol M.

Clin Cancer Res. 2019 Oct 1;25(19):5859-5865. doi: 10.1158/1078-0432.CCR-19-0859. Epub 2019 Jul 29.

PMID:
31358545
9.

A giant bleeding liver mucinous cystic neoplasm.

Andrade DC, Chassaing C, Mamodaly M, Montasser A, Paradis V, Sepulveda A, Cazals-Hatem D.

Liver Int. 2019 Oct;39(10):1999-2000. doi: 10.1111/liv.14190. Epub 2019 Jul 28. No abstract available.

PMID:
31287227
10.

Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery.

Dokmak S, Aussilhou B, Rasoaherinomenjanahary F, Ronot M, Dahdouh R, Ftériche FS, Cauchy F, Paradis V, Belghiti J, Soubrane O.

HPB (Oxford). 2018 Dec;20(12):1198-1205. doi: 10.1016/j.hpb.2018.06.1796. Epub 2018 Jul 7.

PMID:
31217088
11.

Molecular and histological correlations in liver cancer.

Calderaro J, Ziol M, Paradis V, Zucman-Rossi J.

J Hepatol. 2019 Sep;71(3):616-630. doi: 10.1016/j.jhep.2019.06.001. Epub 2019 Jun 10. Review.

PMID:
31195064
12.

Prospective memory assessment in acute mild traumatic brain injury.

Lajeunesse A, Potvin MJ, Audy J, Paradis V, Giguère JF, Rouleau I.

Clin Neuropsychol. 2019 Oct;33(7):1175-1194. doi: 10.1080/13854046.2019.1598500. Epub 2019 Apr 22.

PMID:
31007154
13.

Polyploidy spectrum: a new marker in HCC classification.

Bou-Nader M, Caruso S, Donne R, Celton-Morizur S, Calderaro J, Gentric G, Cadoux M, L'Hermitte A, Klein C, Guilbert T, Albuquerque M, Couchy G, Paradis V, Couty JP, Zucman-Rossi J, Desdouets C.

Gut. 2019 Apr 12. pii: gutjnl-2018-318021. doi: 10.1136/gutjnl-2018-318021. [Epub ahead of print]

14.

Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

Hobeika C, Cauchy F, Poté N, Rautou PE, Durand F, Farges O, Dokmak S, Vilgrain V, Ronot M, Paradis V, Soubrane O.

World J Surg. 2019 Aug;43(8):2048-2060. doi: 10.1007/s00268-019-04996-y.

PMID:
30949764
15.

Digital pathology, what is the future?

Paradis V, Quaglia A.

J Hepatol. 2019 May;70(5):1016-1018. doi: 10.1016/j.jhep.2018.03.023. Epub 2019 Mar 8. No abstract available.

PMID:
30857782
16.

Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.

Hollande C, Boussier J, Ziai J, Nozawa T, Bondet V, Phung W, Lu B, Duffy D, Paradis V, Mallet V, Eberl G, Sandoval W, Schartner JM, Pol S, Barreira da Silva R, Albert ML.

Nat Immunol. 2019 Mar;20(3):257-264. doi: 10.1038/s41590-019-0321-5. Epub 2019 Feb 18.

PMID:
30778250
17.

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN.

Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.

PMID:
30689971
18.

Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset.

Nicolle R, Raffenne J, Paradis V, Couvelard A, de Reynies A, Blum Y, Cros J.

Cancers (Basel). 2019 Jan 21;11(1). pii: E126. doi: 10.3390/cancers11010126.

19.

Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.

Evrard D, Szturz P, Tijeras-Raballand A, Astorgues-Xerri L, Abitbol C, Paradis V, Raymond E, Albert S, Barry B, Faivre S.

Oral Oncol. 2019 Jan;88:29-38. doi: 10.1016/j.oraloncology.2018.10.040. Epub 2018 Nov 20. Review.

PMID:
30616794
20.

Lessons learnt from pathologic imaging correlation in the liver: an historical perspective.

Purcell Y, Copin P, Paradis V, Vilgrain V, Ronot M.

Br J Radiol. 2019 May;92(1097):20180701. doi: 10.1259/bjr.20180701. Epub 2019 Jan 10. Review.

PMID:
30604641
21.

Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome.

Laouirem S, Sannier A, Norkowski E, Cauchy F, Doblas S, Rautou PE, Albuquerque M, Garteiser P, Sognigbé L, Raffenne J, van Beers BE, Soubrane O, Bedossa P, Cros J, Paradis V.

Oncogene. 2019 Apr;38(16):3033-3046. doi: 10.1038/s41388-018-0597-1. Epub 2018 Dec 21.

22.

Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.

Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M, Erkan M, Kleeff J, Wilson J, Apte M, Tosolini M, Wilson AS, Delvecchio FR, Bousquet C, Paradis V, Hammel P, Sadanandam A, Kocher HM.

J Pathol. 2019 May;248(1):51-65. doi: 10.1002/path.5224. Epub 2019 Feb 22.

23.

[A liver tumor in an immunodeficient patient].

Depoilly T, Poté N, Cazals-Hatem D, Paradis V.

Ann Pathol. 2019 Feb;39(1):54-56. doi: 10.1016/j.annpat.2018.07.012. Epub 2018 Dec 12. French. No abstract available.

PMID:
30553638
24.

Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non-Tumor Liver.

Le Faouder J, Gigante E, Léger T, Albuquerque M, Beaufrère A, Soubrane O, Dokmak S, Camadro JM, Cros J, Paradis V.

Proteomics Clin Appl. 2019 Jan;13(1):e1800128. doi: 10.1002/prca.201800128. Epub 2018 Dec 19.

PMID:
30520266
25.

Obesity-induced pancreatopathy in rats is reversible after bariatric surgery.

Rebours V, Garteiser P, Ribeiro-Parenti L, Cavin JB, Doblas S, Pagé G, Bado A, Couvineau A, Ruszniewski P, Paradis V, Le Gall M, Van Beers BE, Couvelard A.

Sci Rep. 2018 Nov 2;8(1):16295. doi: 10.1038/s41598-018-34515-3.

26.

Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.

Lejealle C, Paradis V, Bruno O, de Raucourt E, Francoz C, Soubrane O, Lebrec D, Bedossa P, Valla D, Mal H, Vilgrain V, Durand F, Rautou PE.

Chest. 2019 Jan;155(1):123-136. doi: 10.1016/j.chest.2018.09.017. Epub 2018 Oct 4.

PMID:
30292761
27.

Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.

Guido M, Alves VAF, Balabaud C, Bathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell LD, Gill RM, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Rautou PE, Theise ND, Thung S, Tsui WMS, Sempoux C, Snover D, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2019 Jan;74(2):219-226. doi: 10.1111/his.13738. Epub 2018 Oct 17. Review.

PMID:
30129657
28.

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver.

Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S, Rautou PE, Albuquerque M, Picq O, Gupta AC, Ferrere G, Gilgenkrantz H, Kiaf B, Toubal A, Beaudoin L, Lettéron P, Moreau R, Lehuen A, Lotersztajn S.

Nat Commun. 2018 Jun 1;9(1):2146. doi: 10.1038/s41467-018-04450-y.

29.

Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy?

van Leeuwen DJ, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell L, Gill RM, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Rautou PE, Sempoux C, Snover DC, Theise ND, Thung SN, Tsui WMS, Quaglia A, Liver Pathology Study Group TI.

Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):565-573. doi: 10.1080/17474124.2018.1481388. Epub 2018 Jun 14. Review.

PMID:
29806950
30.

Hepatocellular nodules in vascular liver diseases.

Sempoux C, Balabaud C, Paradis V, Bioulac-Sage P.

Virchows Arch. 2018 Jul;473(1):33-44. doi: 10.1007/s00428-018-2373-6. Epub 2018 May 26. Review.

PMID:
29804132
31.

Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.

Bienaimé F, Ambolet A, Aussilhou B, Brazier F, Fouchard M, Viau A, Barre P, Tissier AM, Correas JM, Paradis V, Terzi F, Friedlander G, Knebelmann B, Joly D, Prié D.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2319-2328. doi: 10.1210/jc.2018-00123.

PMID:
29618028
32.

Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis.

Payancé A, Silva-Junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, Roux O, Nekachtali O, Baiges A, Hernández-Gea V, Laouénan C, Lebrec D, Albuquerque M, Paradis V, Moreau R, Valla D, Durand F, Boulanger CM, Garcia-Pagan JC, Rautou PE.

Hepatology. 2018 Oct;68(4):1508-1518. doi: 10.1002/hep.29903. Epub 2018 May 21.

PMID:
29603327
33.

Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.

Nault JC, Couchy G, Caruso S, Meunier L, Caruana L, Letouzé E, Rebouissou S, Paradis V, Calderaro J, Zucman-Rossi J.

Hepatology. 2018 Sep;68(3):964-976. doi: 10.1002/hep.29884. Epub 2018 Jun 6.

PMID:
29572896
34.

Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.

Schmitt C, Lenglet H, Yu A, Delaby C, Benecke A, Lefebvre T, Letteron P, Paradis V, Wahlin S, Sandberg S, Harper P, Sardh E, Sandvik AK, Hov JR, Aarsand AK, Chiche L, Bazille C, Scoazec JY, To-Figueras J, Carrascal M, Abian J, Mirmiran A, Karim Z, Deybach JC, Puy H, Peoc'h K, Manceau H, Gouya L.

J Intern Med. 2018 Jul;284(1):78-91. doi: 10.1111/joim.12750. Epub 2018 Mar 26.

PMID:
29498764
35.

In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma.

Dayot S, Speisky D, Couvelard A, Bourgoin P, Gratio V, Cros J, Rebours V, Sauvanet A, Bedossa P, Paradis V, Ruszniewski P, Couvineau A, Voisin T.

Oncotarget. 2018 Jan 9;9(6):6952-6967. doi: 10.18632/oncotarget.24084. eCollection 2018 Jan 23.

36.

Benign and malignant hepatocellular lesions in patients with vascular liver diseases.

Vilgrain V, Paradis V, Van Wettere M, Valla D, Ronot M, Rautou PE.

Abdom Radiol (NY). 2018 Aug;43(8):1968-1977. doi: 10.1007/s00261-018-1502-7.

PMID:
29460040
37.

cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.

Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, Gouw A, Kagen A, Klimstra D, Komuta M, Kondo F, Miksad R, Nakano M, Nakanuma Y, Ng I, Paradis V, Nyun Park Y, Quaglia A, Roncalli M, Roskams T, Sakamoto M, Saxena R, Sempoux C, Sirlin C, Stueck A, Thung S, Tsui WMS, Wang XW, Wee A, Yano H, Yeh M, Zen Y, Zucman-Rossi J, Theise N.

Hepatology. 2018 Jul;68(1):113-126. doi: 10.1002/hep.29789. Epub 2018 May 9.

38.

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J.

Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.

PMID:
29281854
39.

Noninvasive assessment of liver steatosis in deceased donors: A pilot study.

Cesaretti M, Poté N, Cauchy F, Dondero F, Dokmak S, Sepulveda A, Schneck AS, Francoz C, Durand F, Paradis V, Soubrane O.

Liver Transpl. 2018 Apr;24(4):551-556. doi: 10.1002/lt.25002. No abstract available.

40.

Volumetric measurement of hepatic tumors: Accuracy of manual contouring using CT with volumetric pathology as the reference method.

Pupulim LF, Ronot M, Paradis V, Chemouny S, Vilgrain V.

Diagn Interv Imaging. 2018 Feb;99(2):83-89. doi: 10.1016/j.diii.2017.11.002. Epub 2017 Dec 6.

41.

Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, Nault JC, Avila MA.

Gut. 2018 Feb;67(2):380-388. doi: 10.1136/gutjnl-2017-315068. Epub 2017 Nov 17. Erratum in: Gut. 2018 Mar;67(3):594.

42.

Cystic fibrosis liver disease in adults: Limits of noninvasive tests of fibrosis.

Hillaire S, Cazals-Hatem D, Erlinger S, Paradis V.

Hepatology. 2018 Feb;67(2):798-799. doi: 10.1002/hep.29637. Epub 2018 Jan 1. No abstract available.

PMID:
29105109
43.

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.

Letouzé E, Shinde J, Renault V, Couchy G, Blanc JF, Tubacher E, Bayard Q, Bacq D, Meyer V, Semhoun J, Bioulac-Sage P, Prévôt S, Azoulay D, Paradis V, Imbeaud S, Deleuze JF, Zucman-Rossi J.

Nat Commun. 2017 Nov 3;8(1):1315. doi: 10.1038/s41467-017-01358-x.

44.

Testing feasibility of an accurate microscopic assessment of macrovesicular steatosis in liver allograft biopsies by smartphone add-on lenses.

Cesaretti M, Poté N, Dondero F, Cauchy F, Schneck AS, Soubrane O, Paradis V, Diaspro A, Antonini A.

Microsc Res Tech. 2018 Jan;81(1):58-63. doi: 10.1002/jemt.22956. Epub 2017 Oct 17.

PMID:
29044859
45.

Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences.

Barbier L, Ronot M, Aussilhou B, Cauchy F, Francoz C, Vilgrain V, Soubrane O, Paradis V, Belghiti J.

Hepatology. 2018 Aug;68(2):652-662. doi: 10.1002/hep.29582. Epub 2018 Jul 11.

PMID:
29023812
46.

Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.

Poté N, Cauchy F, Albuquerque M, Cros J, Soubrane O, Bedossa P, Paradis V.

Liver Int. 2018 Apr;38(4):687-694. doi: 10.1111/liv.13585. Epub 2017 Sep 24.

PMID:
28872754
47.

Liver transplantation in adult cystic fibrosis: Clinical, imaging, and pathological evidence of obliterative portal venopathy.

Hillaire S, Cazals-Hatem D, Bruno O, de Miranda S, Grenet D, Poté N, Soubrane O, Erlinger S, Lacaille F, Mellot F, Vilgrain V, Paradis V.

Liver Transpl. 2017 Oct;23(10):1342-1347. doi: 10.1002/lt.24842. No abstract available.

48.

Ultra-short bowel is an independent risk factor for liver fibrosis in adults with home parenteral nutrition.

Cazals-Hatem D, Billiauws L, Rautou PE, Bondjemah V, Poté N, Corcos O, Paradis V, Joly F.

Liver Int. 2018 Jan;38(1):174-182. doi: 10.1111/liv.13545. Epub 2017 Sep 2.

PMID:
28792647
49.

Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness.

Sharma S, Maras JS, Das S, Hussain S, Mishra AK, Shasthry SM, Sharma CB, Weiss E, Elkrief L, Rautou PE, Gilgenkrantz H, Lotersztajn S, Paradis V, de la Grange P, Junot C, Moreau R, Sarin SK.

Sci Rep. 2017 Jul 28;7(1):6816. doi: 10.1038/s41598-017-07161-4.

50.

Molecular classification of hepatocellular adenoma in clinical practice.

Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J.

J Hepatol. 2017 Nov;67(5):1074-1083. doi: 10.1016/j.jhep.2017.07.009. Epub 2017 Jul 19. Review.

PMID:
28733222

Supplemental Content

Loading ...
Support Center